• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮摩尔浓度的血小板活化因子动员钙离子以改变血小板形状,而不激活磷脂酶C或蛋白激酶C;细胞内游离钙浓度和聚集的同步荧光测定。

Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.

作者信息

James-Kracke M R, Sexe R B, Shukla S D

机构信息

Department of Pharmacology, School of Medicine, University of Missouri, Columbia.

出版信息

J Pharmacol Exp Ther. 1994 Nov;271(2):824-31.

PMID:7965802
Abstract

The purpose of this study was to investigate signal transduction mechanisms activated by low and high concentrations of platelet-activating factor (PAF) in rabbit platelets and to contrast the responses to those induced by thrombin. We measured changes in intracellular free calcium ([Ca++]i) with fura2, while monitoring light scatter simultaneously as a measure of shape change and aggregation in a dual-excitation dual-emission spectrofluorometer. An abrupt 20% fall in light scatter, coincident with the peak of the [Ca++]i, indicated shape change in Ca-containing or Ca-free medium and was blocked by BAPTA loading and 10 microM cytochalasin B. A secondary decline in light scatter, indicating aggregation, occurred only in Ca-containing medium and only under conditions favoring protein kinase C (PKC) activation. PAF at 10(-12) M did not increase 1,4,5-inositol triphosphate content, which suggested PKC would not be activated. However, PAF at 10(-12) rapidly increased [Ca++]i to 900 nM in 7 sec seemingly by Ca influx through receptor-operated channels inducing shape change. PAF at 10(-9) and 10(-8) M increased [Ca++]i to 2 microM in 12 sec and induced both shape change and aggregation. However, in platelets pretreated with 100 nM staurosporine to inhibit protein kinases, 10(-9) M PAF did not cause aggregation even though [Ca++]i still rose to 2 microM, which indicated that PKC plays a role in aggregation but not in Ca++ mobilization.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究的目的是调查低浓度和高浓度血小板活化因子(PAF)在兔血小板中激活的信号转导机制,并将其反应与凝血酶诱导的反应进行对比。我们使用fura2测量细胞内游离钙([Ca++]i)的变化,同时在双激发双发射荧光分光光度计中监测光散射,以此作为形状变化和聚集的指标。光散射突然下降20%,与[Ca++]i的峰值同时出现,表明在含钙或无钙培养基中发生了形状变化,并且被BAPTA负载和10 microM细胞松弛素B所阻断。光散射的二次下降,表明发生了聚集,仅在含钙培养基中且仅在有利于蛋白激酶C(PKC)激活的条件下发生。10^(-12) M的PAF不会增加1,4,5-肌醇三磷酸含量,这表明PKC不会被激活。然而,10^(-12) M的PAF在7秒内迅速将[Ca++]i增加到900 nM,似乎是通过受体操纵通道的钙内流诱导形状变化。10^(-9) M和10^(-8) M的PAF在12秒内将[Ca++]i增加到2 microM,并诱导形状变化和聚集。然而,在用100 nM星形孢菌素预处理以抑制蛋白激酶的血小板中,10^(-9) M的PAF即使[Ca++]i仍升至2 microM也不会引起聚集,这表明PKC在聚集中起作用,但在Ca++动员中不起作用。(摘要截断于250字)

相似文献

1
Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.皮摩尔浓度的血小板活化因子动员钙离子以改变血小板形状,而不激活磷脂酶C或蛋白激酶C;细胞内游离钙浓度和聚集的同步荧光测定。
J Pharmacol Exp Ther. 1994 Nov;271(2):824-31.
2
Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.血小板激活因子对兔血小板中酪氨酸激酶的刺激作用及其与磷脂酶C的关系:染料木黄酮和抗磷酸酪氨酸单克隆抗体的研究
Mol Pharmacol. 1990 Apr;37(4):519-25.
3
Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.血小板活化因子通过受体介导和蛋白激酶依赖性途径促进原代人成纤维细胞生长
Mol Carcinog. 1997 Dec;20(4):366-75.
4
Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms.鸟嘌呤核苷酸结合蛋白和酪氨酸激酶在A431细胞中血小板活化因子激活磷脂酶C的作用:关于双重机制的提议
J Pharmacol Exp Ther. 1993 Aug;266(2):1106-12.
5
Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.仓鼠和豚鼠肺泡巨噬细胞中血小板活化因子受体介导的钙离子反应差异。
J Pharmacol Exp Ther. 1997 Jun;281(3):1047-58.
6
Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.血小板活化因子(PAF)受体介导的神经杂交瘤NG108 - 15细胞中的钙动员和磷酸肌醇代谢:新型PAF拮抗剂BN50739的研究
J Pharmacol Exp Ther. 1991 Apr;257(1):374-81.
7
Mechanism and regulation of neutrophil priming by platelet-activating factor.血小板活化因子对中性粒细胞启动的作用机制及调控
J Cell Physiol. 1993 Jul;156(1):189-97. doi: 10.1002/jcp.1041560125.
8
Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms.血小板活化因子通过钙/磷脂依赖性机制作用于灌注的豚鼠肾上腺皮质醇分泌。
J Endocrinol. 2005 Feb;184(2):381-91. doi: 10.1677/joe.1.05937.
9
Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line.在人B细胞系中,磷脂酶C的酪氨酸磷酸化与其被血小板活化因子激活相伴发生。
J Immunol. 1993 Jul 15;151(2):637-48.
10
Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
Mol Pharmacol. 1989 Apr;35(4):409-13.

引用本文的文献

1
Rapid production of platelet-activating factor is induced by protein kinase Cα-mediated phosphorylation of lysophosphatidylcholine acyltransferase 2 protein.蛋白激酶 Cα介导的溶血磷脂酰胆碱酰基转移酶 2 蛋白磷酸化诱导血小板活化因子的快速产生。
J Biol Chem. 2014 May 30;289(22):15566-76. doi: 10.1074/jbc.M114.558874. Epub 2014 Apr 17.
2
Role of platelets in neuroinflammation: a wide-angle perspective.血小板在神经炎症中的作用:一个广阔的视角。
J Neuroinflammation. 2010 Feb 3;7:10. doi: 10.1186/1742-2094-7-10.
3
The influence of platelet activating factor on the effects of platelet agonists and antiplatelet agents in vitro.
J Thromb Thrombolysis. 2009 Jul;28(1):38-45. doi: 10.1007/s11239-008-0239-5. Epub 2008 Jun 25.
4
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
Br J Pharmacol. 1996 Jun;118(4):941-50. doi: 10.1111/j.1476-5381.1996.tb15490.x.